首页 | 本学科首页   官方微博 | 高级检索  
检索        

通冠复脉汤治疗冠心病室性早搏38例
引用本文:晏明英,邓志,徐德伟,江玉.通冠复脉汤治疗冠心病室性早搏38例[J].中国实验方剂学杂志,2014,20(7):199-203.
作者姓名:晏明英  邓志  徐德伟  江玉
作者单位:四川达州市中西医结合医院, 四川 达州 635000;四川达州市中西医结合医院, 四川 达州 635000;四川达州市中西医结合医院, 四川 达州 635000;泸州医学院附属中医院, 四川 泸州 646000
基金项目:四川省教育厅项目(川教函[2011]538号11ZB130);泸州市科技局项目(泸市科[2012]177)
摘    要:目的:探讨通冠复脉汤治疗冠心病(CHD)室性早搏的临床疗效及对血管内皮功能的影响。方法:将77例CHD室性早搏急患者按住院先后随机分为对照组39和观察组38例。两组均给予常规西医治疗,对照组,美托洛尔缓释片,50 mg/次,1次/d。观察组在对照组的基础上加服通冠复脉汤,1剂/d,常规水煎分2次服用。两组疗程均为12周。记录治疗前后心悸、胸痛、神疲乏力、气短及唇色紫暗等主要症状评分;采用24 h动态心电图记录治疗前后室性早搏的次数;记录每周心绞痛发作次数及每次持续时间;检测治疗前后血清一氧化氮(NO),内皮素1(ET-1),血栓素(TXB2)及6-酮-前列腺素F_(1a)(6-Keto-PGF_1a)水平。结果:观察组心律失常总有效率为92.11%,优于对照组的74.36%(P<0.05);经Ridit分析,观察组心电图疗效优于对照组(P<0.05);治疗后观察组心绞痛发作次数及持续时间均少于对照组(P<0.05或P<0.01);观察组心悸、胸痛、神疲乏力、气短及唇色紫暗等症状评分低于对照组(P<0.01);观察组NO和6-Keto-PGF-1a高于对照组,ET-1和TXB2低于对照组(P<0.01)。结论:通冠复脉汤能治冠心病(CHD)室性早搏患者临床症状、心电图缺血改变、室性早搏均有显著改善作用,临床疗效显著,其作用机制可能与改善患者血管内皮功能,增加心肌血供有关。

关 键 词:冠心病  室性早搏  通冠复脉汤  血管内皮功能
收稿时间:2013/12/2 0:00:00

Tongguan Fumai Decoction to Treat Ventricular Premature Beat in Coronary Heart Disease of 38 Cases
YAN Ming-ying,DENG Zhi,XU De-wei and JIANG Yu.Tongguan Fumai Decoction to Treat Ventricular Premature Beat in Coronary Heart Disease of 38 Cases[J].China Journal of Experimental Traditional Medical Formulae,2014,20(7):199-203.
Authors:YAN Ming-ying  DENG Zhi  XU De-wei and JIANG Yu
Institution:Combined With the Sichuan Dazhou City Hospital of Traditional Chinese Medicine Western Medicine, Dazhou 635000, China;Combined With the Sichuan Dazhou City Hospital of Traditional Chinese Medicine Western Medicine, Dazhou 635000, China;Combined With the Sichuan Dazhou City Hospital of Traditional Chinese Medicine Western Medicine, Dazhou 635000, China;Luzhou Medical College Affiliated hospital of Traditional Chinese Medicine, Luzhou 646000, China
Abstract:Objective: The purpose is to discuss the clinical effects of Tongguan Fumai decoction on ventricular premature beat in coronary heart disease (CHD) and the influence of vascular endothelial function. Method: Seventy-seven cases of patients with were randomly divided into control group (39 cases) and observation group (38 cases) according to the oder of being in hospital.Both groups were treated with regular western medicine treatment.In control group,patients took metoprolol sustained-release tablets,50 mg/time,1 does/day.For patients in observation group took Tongguan Fumai decoction based on control group,1 does/day, conventional water decoction,taken orally.The treatment course was 12 weeks for both groups.Record symptom score of palpitation,chest pain,spirit fatigue,breathe hard and dark purple color on lip before and after treatment. Keep a record of the number of ventricular premature beat by 24 hours dynamic electrocardiogram.Besides,record number of angina pectoris attack times and duration time within a week.Detect serum nitric oxide(NO),endothelin-1(ET-1), thromboxane (TXB2) and 6-ketone-prostaglandin F_(1a) (6-Keto-PGF_1a) before and after treatment. Result: After the treatment,total effective rate of arrhythmia in observation group was 92.11%,which was better than 74.36% in control group(P<0.05).Electrocardiograph curative effect in observation group was superior to control group(P<0.01) by analysis of Ridit.The number of angina pectoris attack times and duration time in observation group were both lower than control group(P<0.05 or P<0.01) after treated.Symptom score of palpitation,chest pain,spirit fatigue,breathe hard and dark purple color on lip in observation group were inferior to control group(P<0.01).For observation group, the level of NO and 6-Keto-PGF_1a were higher than control group,but ET-1 and TXB2were lower (P<0.01). Conclusion: Through the treatment of Tongguan Fumai decoction. It can improve patients with CHD ventricular premature beat in clinical symptoms,electrocardiograph ischemia change and ventricular premature beat.As for the effective clinical effects, its mechanism of action may be because it improve patients' vascular endothelial function and increase myocardial blood supply.
Keywords:coronary heart disease  ventricular premature beat  Tongguan Fumai decoction  vascular endothelial function
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号